The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
If chronic Hepatitis C escalates to advanced disease that includes hepatic encephalopathy, Lactulose and Xifaxan could be useful medications.
Continue reading »Although diagnosing Hepatitis C is easier with the rapid antibody test, efforts to educate and test the public on this extremely common disease need to be prioritized.
Continue reading »Find out about a report that highlights some large, seemingly preventable gaps in Hepatitis B care.
Continue reading »In response to a story used in Vertex's marketing campaign, the FDA has warned the pharmaceutical company that their promotional piece may mislead consumers about the Hepatitis C drug, Incivek.
Continue reading »Thanks to a recent multi-study review, we now have a better understanding of the Hepatitis C transmission risk from getting a tattoo.
Continue reading »Two vitamins and the universal antioxidant may be able to interfere with the acceleration of cellular damage in those with both Hepatitis C and COPD.
Continue reading »In just three weeks, the Hepatitis C drug in development, GS-7977, led to a sustained virologic response in over 90 percent of patients when paired with ribavirin and pegylated interferon.
Continue reading »Of concern to those co-infected with Hepatitis C and HIV, the FDA has confirmed that the Hep C drug, boceprevir, interferes with the HIV drug, ritonavir.
Continue reading »To assist with drug safety in the presence of Hepatitis C infection, patients are urged to take an active role in managing their medications.
Continue reading »Treatment naïve patients with Hepatitis C genotype 1 boasted a 100 percent success rate when given Gilead's GS-7977 and Bristol-Myers Squibb's daclatasvir.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
